Search results for: Health Policy and Regulation
Filter search results
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…authorities. Hildegarde Naughton (Department of Health, Ireland) exampled Ireland’s implementation of ‘The Healthy Ireland Framework’, which aims to improve wellbeing by addressing health determinants including education, transport, housing, and environment….
Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool
9 September 2024
…of Understanding (MOU) on “Collaboration on Priority Setting and Early Health Technology Assessment of Health Innovation in Thailand”, including HITAP, Thailand Science Research and Innovation (TSRI), Thailand Center of Excellence for…
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…Wong, O., 2019. Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare. The European Journal of Health Economics, 20(3), pp.427–438. 10.1007/s10198-018-1007-x. Khorasani, E.,…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…that the way child QALYs are measured and valued is a good ‘fit’ with the principles and social value judgements used in HTA and health policy. These might not be…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…This award recognises individuals who have made outstanding, life-long contributions to improving health outcomes through research, leadership, and impact in the field of health economics and outcomes research. Adrian’s work…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…https://www.fiercepharma.com/pharma/after-pfizer-deal-sanofi-offers-a-hand-to-johnson-johnson-for-covid-19-vaccine-production [Accessed 17 May 2021]. McClellan, M. and Udayakumar, K., 2021. Reducing Global COVID Vaccine Shortages: New Research and Recommendations for US Leadership. [online] Available at: https://healthpolicy.duke.edu/publications/reducing-global-covid-vaccine-shortages-new-research-and-recommendations-us-leadership [Accessed 17 May…
Is the revised Congressional Budget Office model of new drug development fit for purpose?
6 May 2026
Summary As the U.S. pricing policy landscape is evolving rapidly, introducing unprecedented changes to how pharmaceuticals are reimbursed and accessed, it is increasingly important to understand the consequences of these…
Global rare‑disease policy shifts: what are the implications for equitable access to orphan medicines?
1 March 2026
…therefore especially sensitive to regulatory and policy changes. However, regulatory incentives for orphan drug research and development (R&D) are often not matched by Health Technology Assessment (HTA) and Pricing and…
The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
14 April 2025
…ultimate aim, and aligns HTA with broader government goals, such as economic growth and improved health and social standards, and addresses health inequities in line with regional cultural values. Despite…